Buspirone for the treatment of anxiety in Williams syndrome: a retrospective chart review study

CONCLUSIONS: In this retrospective study, the majority of patients responded to a 16-week course of buspirone. Prospective studies are warranted to further assess the efficacy and tolerability of buspirone for anxiety in WS.PMID:38247447 | DOI:10.1080/14656566.2024.2308678

Source: Expert Opinion on Pharmacotherapy - January 22, 2024 Category: Drugs & Pharmacology Authors: Eva Shin Danielle Renzi Camila Canales Caitlin Ravichandran Christopher J McDougle Robyn P Thom Source Type: research